Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Execs Should Monitor Advocacy Group Concerns, Media Coverage – Diermeier

This article was originally published in The Gray Sheet

Executive Summary

Medical device executives should stay abreast of advocacy group concerns and media portrayal in order to effectively manage the image of their products, according to Daniel Diermeier, PhD, Northwestern University

You may also be interested in...

Mentor Awaits Breast Implant Approval; Advocacy Groups Fight To Stop FDA

Mentor acknowledges that saline breast implant sales could slow in anticipation of silicone breast implant approval imminently

Grassley Requests FDA Info On Guidant ICD Alerts Following NEJM Article

Senate Finance Committee Chair Chuck Grassley (R-Iowa) is asking FDA for a detailed briefing on the "regulatory history" of Guidant's Ventak Prizm 2 DR ICD and the agency's plans to address medical device safety issues

Digene Uses Pharma DTC/Physician-Sales Model To Drive HPV Test Adoption

Digene is channeling its 65-rep clinician sales force and direct-to-consumer advertising to make DNAwithPap tests the standard of care for cervical cancer screening

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts